Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Insulet Corporation (PODD) PT Lowered to $310 at BTIG
February 24, 2022 12:59 PM ESTBTIG analyst Marie Thibault lowered the price target on Insulet Corporation (NASDAQ: PODD) to $310.00 (from $320.00) while maintaining a Buy rating.
The analyst commented, "Insulet reported Q4 revenue of $307.7M (+25% y/y rep, +25.7% y/y cc), beating consensus estimates of $299.3M and our $303.2M forecast. U.S. Omnipod revenue was relatively in line with our expectations but OUS headwinds, including ongoing pressures from competitive AID systems and an estimated $5M... More
Insulet (PODD) Tops Q4 EPS by 10c
February 23, 2022 4:07 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of $0.42, $0.10 better than the analyst estimate of $0.32. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $301.06 million.
GUIDANCE:
For the year ending December 31, 2022, the Company expects revenue growth in... More
